DUBLIN--(BUSINESS WIRE)--The "Epigenetic Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering.
The global epigenetic therapeutics market was valued at $6.4 billion in 2022. The market is expected to reach $9.8 billion by 2028, growing at a compound annual growth rate (CAGR) of 7.7% over the forecast period.
Technological innovations in epigenetic drug discovery and development are driving increased use of epigenetic therapeutics, which also is pushing market growth. However, loss of exclusivity in the case of a few branded drugs and the entry of generic drugs into the market is the restraining the growth of this market.
This report is a comprehensive study of the global market for epigenetic therapeutics. It describes the epigenetic therapeutics market, which is segmented by product type and region. Based on product type, the market is segmented into PRAP inhibitors, Kinase inhibitors, IDH inhibitors, HDAC inhibitorsHDAC inhibitors, DNMT inhibitorsDNMT inhibitors and KMT inhibitors. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific, and the Rest of the World (RoW). This report examines the factors driving growth in the epigenetic drugs market, and it reviews major players, established companies and new entrants. The report, however, does not cover epigenetic diagnostic assays and instruments.
A comprehensive overview of the global markets for epigenetic therapeutics
Analyses of the global market trends with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
Understanding of the upcoming market potential for epigenetic therapeutics with an emphasis on new products and technologies, and areas of focus to forecast this market into various segments and sub-segments
Estimation of the actual market size and revenue forecast for the global epigenetic therapeutics market, and corresponding market share analysis product type and region
In-depth information (facts and figures) concerning major market dynamics (DROs), technology advancements, new products and applications in epigenomics, and COVID-19 impact on the industry Coverage of the technological, economic, and business considerations of the market for epigenetic therapeutics, with analyses and growth forecasts through 2028
A look at the recent breakthrough innovations, key technological issues, market regulations, and current status on the intellectual property rights on epigenetic therapeutics
Review of patent trends and research publications for innovations in the genome-editing technologies
Insight into the recent industry structure, government regulations and policies, development issues, and the vendor landscape
Analysis of the competitive environment and market opportunities based on the company's business strategies, product mapping, and operational integration
Study Goals and Objectives
Reasons for Doing this Study
Chapter 2 Summary and Highlights
Highlights of the Market for Epigenetic Therapeutics
Chapter 3 Market Overview and Definitions
Risk of Cancer in Major Countries Penetration of Targeted Medicine in Emerging Markets
Chapter 5 Market Breakdown by Product Type
Impact of COVID-19 on the Medical Devices and Pharmaceutical Industries Decline/Delay in Elective Procedures
Impact of COVID-19 on Medical Device and Pharmaceutical Product Segments Impact of COVID-19 on Epigenetic Therapeutics Markets Chapter 7 Market Breakdown by Region
Market Overview and Discussion
Chapter 8 Emerging/Upcoming Technologies
Chapter 9 Competitive Landscape
Chapter 10 Patent Analysis
Patent Analysis, by Manufacturer
Chapter 11 Pipeline Analysis
Chapter 12 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/kdiz64
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.